{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T04:00:03Z","timestamp":1791000003224,"version":"4.1.0"},"reference-count":297,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.coph.2019.05.008","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T06:04:27Z","timestamp":1562652267000},"page":"122-142","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Sex differences in the pharmacology of itch therapies\u2014a narrative review"],"prefix":"10.1016","volume":"46","author":[{"given":"Yasmin","family":"Schmid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zita-Rose Manjaly","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Pfleiderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Kr\u00e4henb\u00fchl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon M","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2019.05.008_bib0005","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S0190-9622(98)70087-8","article-title":"How should we define itching?","volume":"39","author":"Savin","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0010","article-title":"Pruritus and dyesthesia","volume":"vol 3","author":"Weisshaar","year":"2012"},{"key":"10.1016\/j.coph.2019.05.008_bib0015","series-title":"Epidemiology of Itch, in Itch: Mechanisms and Treatment","author":"Weisshaar","year":"2014"},{"key":"10.1016\/j.coph.2019.05.008_bib0020","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2340\/00015555-0305","article-title":"Clinical classification of itch: a position paper of the international forum for the study of itch","volume":"87","author":"Staender","year":"2007","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000446009","article-title":"Classification of itch","volume":"50","author":"Staender","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.alit.2016.08.009","article-title":"Assessment of severity and burden of pruritus","volume":"66","author":"Pereira","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.coph.2019.05.008_bib0035","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000446010","article-title":"Epidemiology of itch","volume":"50","author":"Weisshaar","year":"2016","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0040","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2340\/00015555-1159","article-title":"Prevalence, correlates and characteristics of chronic pruritus: a population-based cross-sectional study","volume":"91","author":"Matterne","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0045","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000319862","article-title":"Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730","volume":"221","author":"Staender","year":"2010","journal-title":"Dermatology"},{"key":"10.1016\/j.coph.2019.05.008_bib0050","doi-asserted-by":"crossref","first-page":"532","DOI":"10.2340\/00015555-1572","article-title":"Incidence and determinants of chronic pruritus: a population-based cohort study","volume":"93","author":"Matterne","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0055","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2340\/00015555-0641","article-title":"Measuring the prevalence of chronic itch in the general population: development and validation of a questionnaire for use in large-scale studies","volume":"89","author":"Matterne","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0060","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2340\/00015555-1221","article-title":"Itch severity and quality of life in patients with pruritus: preliminary validity of a Danish adaptation of the itch severity scale","volume":"92","author":"Zachariae","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0065","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2340\/00015555-2263","article-title":"Quality of life, emotional wellbeing and family repercussions in dermatological patients experiencing chronic itching: a pilot study","volume":"96","author":"Marron","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0070","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/jid.2014.530","article-title":"The psychological burden of skin diseases: a cross-sectional multicenter study among dermatological out-patients in 13 European countries","volume":"135","author":"Dalgard","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0075","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.neuroscience.2013.07.035","article-title":"Neural processing of itch","volume":"250","author":"Akiyama","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.coph.2019.05.008_bib0080","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/ejp.778","article-title":"Many parallels between itch and pain research","volume":"20","author":"Carstens","year":"2016","journal-title":"Eur J Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrcardio.2016.171","article-title":"Atrial fibrillation in women: treatment","volume":"14","author":"Ko","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.coph.2019.05.008_bib0090","doi-asserted-by":"crossref","DOI":"10.1007\/s11883-016-0562-9","article-title":"Women versus men: is there equal benefit and safety from statins?","volume":"18","author":"Plakogiannis","year":"2016","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.coph.2019.05.008_bib0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijpharm.2011.04.069","article-title":"Does sex matter? The influence of gender on gastrointestinal physiology and drug delivery","volume":"415","author":"Freire","year":"2011","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2019.05.008_bib0100","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4070\/kcj.2016.46.4.433","article-title":"Women and ischemic heart disease: recognition, diagnosis and management","volume":"46","author":"Park","year":"2016","journal-title":"Korean Circ J"},{"key":"10.1016\/j.coph.2019.05.008_bib0105","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2005-861249","article-title":"Sex\/gender research \u2014 introduction and anesthesiological aspects","volume":"40","author":"Verner","year":"2005","journal-title":"Anasthesiol Intensivmed Notfallmed Schmerzther"},{"key":"10.1016\/j.coph.2019.05.008_bib0110","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1016\/j.jalz.2016.08.004","article-title":"Sex biology contributions to vulnerability to Alzheimer\u2019s disease: a think tank convened by the Women\u2019s Alzheimer\u2019s Research Initiative","volume":"12","author":"Snyder","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.coph.2019.05.008_bib0115","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1111\/dmcn.13137","article-title":"Sex differences in cerebral palsy on neuromotor outcome: a critical review","volume":"58","author":"Romeo","year":"2016","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.coph.2019.05.008_bib0120","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/YCO.0000000000000243","article-title":"Issues related to sex differences in antipsychotic treatment","volume":"29","author":"Crawford","year":"2016","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0125","first-page":"266","article-title":"Gender aspects in gastrointestinal tumours and their prognosis in regard to multimodal treatment concepts","volume":"140","author":"Seeland","year":"2015","journal-title":"Zentralbl Chir"},{"key":"10.1016\/j.coph.2019.05.008_bib0130","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/15569520600860355","article-title":"Gender: a possible determinant in dosing of dermatologic drugs\u2014an overview","volume":"25","author":"Modjtahedi","year":"2006","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.coph.2019.05.008_bib0135","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/j.1468-3083.2010.03668.x","article-title":"Gender aspects in skin diseases","volume":"24","author":"Chen","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0140","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/rheumatology\/keu247","article-title":"Gender-specific differences in Adamantiades-Behcet\u2019s disease manifestations: an analysis of the German registry and meta-analysis of data from the literature","volume":"54","author":"Bonitsis","year":"2015","journal-title":"Rheumatology (Oxford)"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2019.05.008_bib0145","article-title":"Training emergency physicians in sex- and gender-based medicine: assessing attitudes of program directors and residency graduates","volume":"7","author":"Madsen","year":"2016","journal-title":"Biol Sex Differ"},{"key":"10.1016\/j.coph.2019.05.008_bib0150","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuroscience.2016.05.007","article-title":"Insights into the mechanisms and the emergence of sex-differences in pain","volume":"338","author":"Melchior","year":"2016","journal-title":"Neuroscience"},{"key":"10.1016\/j.coph.2019.05.008_bib0155","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/jnr.23841","article-title":"Sex differences in pain","volume":"95","author":"Sorge","year":"2017","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.coph.2019.05.008_bib0160","series-title":"Sex- and Gender-Specific Differences in Chronic Pruritus, in Pruritus","first-page":"117","author":"Stumpf","year":"2016"},{"key":"10.1016\/j.coph.2019.05.008_bib0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079123","article-title":"Sex differences in itch perception and modulation by distraction\u2014an FMRI pilot study in healthy volunteers","volume":"8","author":"Stumpf","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.008_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2340\/00015555-1894","article-title":"Gender differences in itch and pain-related sensations provoked by histamine, cowhage and capsaicin","volume":"95","author":"Hartmann","year":"2015","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0175","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/bjd.14910","article-title":"Chronic pruritus: evaluation of patient needs and treatment goals with a special regard to differences according to pruritus classification and sex","volume":"176","author":"Steinke","year":"2017","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0180","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/bjd.13492","article-title":"Relations between the characteristics and psychological comorbidities of chronic pruritus differ between men and women: women are more anxious than men","volume":"172","author":"Stumpf","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ad.2016.12.002","article-title":"Differences between men and women in chronic scratching: a psychodermatologic study in lichen simplex chronicus","author":"Martin-Brufau","year":"2017","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.coph.2019.05.008_bib0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.lfs.2013.10.036","article-title":"Sex-related differences in SLIGRL-induced pruritus in mice","volume":"94","author":"Yamaura","year":"2014","journal-title":"Life Sci"},{"key":"10.1016\/j.coph.2019.05.008_bib0195","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ejphar.2005.06.019","article-title":"Spontaneous scratching behavior in MRL\/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride","volume":"518","author":"Umeuchi","year":"2005","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0200","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pain.2006.03.023","article-title":"Influence of genotype, dose and sex on pruritogen-induced scratching behavior in the mouse","volume":"124","author":"Green","year":"2006","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0205","doi-asserted-by":"crossref","first-page":"573","DOI":"10.2340\/00015555-1599","article-title":"Itch characteristics in five dermatoses: non-atopic eczema, atopic dermatitis, urticaria, psoriasis and scabies","volume":"93","author":"Brenaut","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0210","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2340\/00015555-1126","article-title":"Differences in itch characteristics between psoriasis and atopic dermatitis patients: results of a web-based questionnaire","volume":"91","author":"O\u2019Neill","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0215","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2340\/00015555-1129","article-title":"Pruritus differences between psoriasis and lichen planus","volume":"91","author":"Reich","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0220","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2340\/00015555-1402","article-title":"Questionnaires to assess chronic itch: a consensus paper of the special interest group of the international forum on the study of itch","volume":"92","author":"Weisshaar","year":"2012","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.coph.2019.05.008_bib0225","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1111\/bjd.12267","article-title":"Gender differences in chronic pruritus: women present different morbidity, more scratch lesions and higher burden","volume":"168","author":"Staender","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0230","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/1523-1747.ep12874474","article-title":"Properties of transdermal histamine iontophoresis: differential effects of season, gender, and body region","volume":"94","author":"Magerl","year":"1990","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0235","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1111\/jne.12072","article-title":"Epigenetic contributions to hormonally-mediated sexual differentiation of the brain","volume":"25","author":"McCarthy","year":"2013","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.coph.2019.05.008_bib0240","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.neubiorev.2017.07.005","article-title":"Sex differences in the brain: implications for behavioral and biomedical research","volume":"85","author":"Choleris","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.coph.2019.05.008_bib0245","doi-asserted-by":"crossref","first-page":"373","DOI":"10.31887\/DCNS.2016.18.4\/jmarrocco","article-title":"Sex in the brain: hormones and sex differences","volume":"18","author":"Marrocco","year":"2016","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.coph.2019.05.008_bib0250","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-30726-3_1","article-title":"Sex and gender differences in clinical medicine","volume":"214","author":"Regitz-Zagrosek","year":"2012","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0255","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2019.00160","article-title":"Does sex\/gender play a role in placebo and nocebo effects? Conflicting evidence from clinical trials and experimental studies","volume":"13","author":"Enck","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/j.coph.2019.05.008_bib0260","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2147\/JPR.S134745","article-title":"A systematic review of sex differences in the placebo and the nocebo effect","volume":"10","author":"Vambheim","year":"2017","journal-title":"J Pain Res"},{"key":"10.1016\/j.coph.2019.05.008_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/978-3-662-44519-8_12","article-title":"Placebo and nocebo effects in itch and pain","volume":"225","author":"Evers","year":"2014","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0270","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1111\/all.12727","article-title":"The imagined itch: brain circuitry supporting nocebo-induced itch in atopic dermatitis patients","volume":"70","author":"Napadow","year":"2015","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2019.05.008_bib0275","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2340\/00015555-1400","article-title":"European guideline on chronic pruritus","volume":"92","author":"Weisshaar","year":"2012","journal-title":"Acta Derm Venereol"},{"issue":"Suppl. 4","key":"10.1016\/j.coph.2019.05.008_bib0280","first-page":"S1","article-title":"S2k guideline\u2014chronic pruritus","volume":"10","author":"Staender","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.coph.2019.05.008_bib0285","first-page":"918","article-title":"Diagnosis and treatment of pruritus","volume":"63","author":"Nowak","year":"2017","journal-title":"Can Fam Phys"},{"key":"10.1016\/j.coph.2019.05.008_bib0290","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.sder.2011.04.008","article-title":"Topical therapies for pruritus","volume":"30","author":"Elmariah","year":"2011","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.coph.2019.05.008_bib0295","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/all.13239","article-title":"Emerging role of interleukin-31 and interleukin-31 receptor in pruritus in atopic dermatitis","volume":"73","author":"Furue","year":"2018","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2019.05.008_bib0300","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1517\/14728214.2015.1051964","article-title":"Emerging drugs for the treatment of pruritus","volume":"20","author":"Staender","year":"2015","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/j.coph.2019.05.008_bib0305","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1080\/10837450902891485","article-title":"Gender and interindividual variability in pharmacokinetics","volume":"41","author":"Nicolas","year":"2009","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.coph.2019.05.008_bib0310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1146\/annurev.pharmtox.44.101802.121453","article-title":"Sex differences in pharmacokinetics and pharmacodynamics","volume":"44","author":"Gandhi","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.coph.2019.05.008_bib0315","article-title":"Sex differences in drug disposition","volume":"2011","author":"Soldin","year":"2011","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/j.coph.2019.05.008_bib0320","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/sj.clpt.6100226","article-title":"The current state of knowledge on age, sex, and their interactions on clinical pharmacology","volume":"82","author":"Schwartz","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0325","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00003088-200241050-00002","article-title":"How important are gender differences in pharmacokinetics?","volume":"41","author":"Meibohm","year":"2002","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0330","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S0002-8223(21)18788-7","article-title":"Estimating the lean body mass of young women. Use of skeletal measurements","volume":"42","author":"Young","year":"1963","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/j.coph.2019.05.008_bib0335","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/00007890-198604000-00009","article-title":"Demographic factors affecting the pharmacokinetics of cyclosporine estimated by radioimmunoassay","volume":"41","author":"Kahan","year":"1986","journal-title":"Transplantation"},{"key":"10.1016\/j.coph.2019.05.008_bib0340","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/clpt.1980.40","article-title":"Diazepam disposition determinants","volume":"27","author":"Greenblatt","year":"1980","journal-title":"Clini Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0345","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1079\/BJN19860116","article-title":"The effect of age, sex and level of intake of dietary fibre from wheat on large-bowel function in thirty healthy subjects","volume":"56","author":"Stephen","year":"1986","journal-title":"Br J Nutr"},{"key":"10.1016\/j.coph.2019.05.008_bib0350","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2982.1995.tb00231.x","article-title":"Influence of age, gender, hormonal status and smoking habits on colonic transit time","volume":"7","author":"Meier","year":"1995","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.coph.2019.05.008_bib0355","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1159\/000137524","article-title":"Diazepam kinetics in relation to age and sex","volume":"23","author":"Ochs","year":"1981","journal-title":"Pharmacology"},{"key":"10.1016\/j.coph.2019.05.008_bib0360","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2125.1981.tb00528.x","article-title":"Sex-related differences in the plasma protein binding of lignocaine and diazepam","volume":"11","author":"Routledge","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0365","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0047-6374(92)90106-N","article-title":"Hepatic cytochrome P-4503A (CYP3A) activity in the elderly","volume":"64","author":"Hunt","year":"1992","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.coph.2019.05.008_bib0370","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/00008571-199408000-00005","article-title":"The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes","volume":"4","author":"Bock","year":"1994","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.coph.2019.05.008_bib0375","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/clpt.1992.203","article-title":"Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities","volume":"52","author":"Relling","year":"1992","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0380","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00008571-200007000-00006","article-title":"Effect of gender, sex hormones, time variables and physiological urinary pH on apparent CYP2D6 activity as assessed by metabolic ratios of marker substrates","volume":"10","author":"Labbe","year":"2000","journal-title":"Pharmacogenetics"},{"key":"10.1016\/j.coph.2019.05.008_bib0385","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0390","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0009-9236(03)00187-5","article-title":"The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity","volume":"74","author":"Gorski","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0395","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00406-006-0662-6","article-title":"The role of the transporter P-glycoprotein for disposition and effects of centrally acting drugs and for the pathogenesis of CNS diseases","volume":"256","author":"Thuerauf","year":"2006","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.coph.2019.05.008_bib0400","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0022-3565(25)12089-2","article-title":"Interindividual variation in expression of P-glycoprotein in normal human liver and secondary hepatic neoplasms","volume":"275","author":"Schuetz","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijpharm.2002.12.002","article-title":"Unmasking the dynamic interplay between efflux transporters and metabolic enzymes","volume":"277","author":"Benet","year":"2004","journal-title":"Int J Pharm"},{"key":"10.1016\/j.coph.2019.05.008_bib0410","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1200\/JCO.2005.01.9232","article-title":"Gender differences in p-glycoprotein: drug toxicity and response","volume":"23","author":"Davis","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.coph.2019.05.008_bib0415","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3109\/03602530903209288","article-title":"Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system","volume":"42","author":"Court","year":"2010","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.coph.2019.05.008_bib0420","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0022-3565(24)29222-3","article-title":"Interindividual variability in acetaminophen glucuronidation by human liver microsomes: identification of relevant acetaminophen UDP-glucuronosyltransferase isoforms","volume":"299","author":"Court","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0425","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2125.1983.tb02207.x","article-title":"Influence of sex and oral contraceptive steroids on paracetamol metabolism","volume":"16","author":"Miners","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0430","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/00007691-200110000-00004","article-title":"In vivo higher glucuronidation of mycophenolic acid in male than in female recipients of a cadaveric kidney allograft and under immunosuppressive therapy with mycophenolate mofetil","volume":"23","author":"Morissette","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.coph.2019.05.008_bib0435","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/j.ajkd.2016.06.021","article-title":"Effects of race and sex on measured GFR: the multi-ethnic study of atherosclerosis","volume":"68","author":"Inker","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.coph.2019.05.008_bib0440","doi-asserted-by":"crossref","first-page":"941","DOI":"10.3109\/00498259209049900","article-title":"Sex difference in the excretion of zenarestat in mice, rats, dogs and humans","volume":"22","author":"Tanaka","year":"1992","journal-title":"Xenobiotica"},{"key":"10.1016\/j.coph.2019.05.008_bib0445","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1365-2125.1995.tb04414.x","article-title":"Chronic tobacco smoking and gender as variables affecting amantadine disposition in healthy subjects","volume":"39","author":"Wong","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0450","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/cod.12621","article-title":"Frequency and trends of contact allergy to and iatrogenic contact dermatitis caused by topical drugs over a 25-year period","volume":"75","author":"Gilissen","year":"2016","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.coph.2019.05.008_bib0455","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2008.00511.x","article-title":"Topical immunomodulators are effective for treatment of vitiligo","volume":"35","author":"Choi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0460","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2133.2008.08974.x","article-title":"Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis","volume":"160","author":"Undre","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0465","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1080\/09546630510033159","article-title":"A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis","volume":"16","author":"Ling","year":"2005","journal-title":"J Dermatolg Treat"},{"key":"10.1016\/j.coph.2019.05.008_bib0470","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1592\/phco.27.7.1020","article-title":"Safety of topical calcineurin inhibitors for the treatment of atopic dermatitis","volume":"27","author":"Munzenberger","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.coph.2019.05.008_bib0475","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.0022-202X.2005.23754.x","article-title":"Pharmacokinetics of 0.1% tacrolimus ointment after first and repeated application to adults with moderate to severe atopic dermatitis","volume":"125","author":"Rubins","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0480","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.0022-202X.2005.23644.x","article-title":"A multicenter study of the pharmacokinetics of tacrolimus ointment after first and repeated application to children with atopic dermatitis","volume":"124","author":"Harper","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0485","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000051813","article-title":"Low systemic exposure after repeated topical application of Pimecrolimus (Elidel), SD Z ASM 981) in patients with atopic dermatitis","volume":"204","author":"Van Leent","year":"2002","journal-title":"Dermatology"},{"key":"10.1016\/j.coph.2019.05.008_bib0490","first-page":"185","article-title":"Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis","volume":"6","author":"Krueger","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0495","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2005-1188","article-title":"Safety and tolerability of 1% pimecrolimus cream among infants: experience with 1133 patients treated for up to 2 years","volume":"117","author":"Paul","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2019.05.008_bib0500","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.jaad.2005.06.013","article-title":"Pharmacokinetics of topical calcineurin inhibitors in adult atopic dermatitis: a randomized, investigator-blind comparison","volume":"53","author":"Draelos","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0505","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/FTD.0b013e3181a8b200","article-title":"Pharmacokinetic analysis of capsaicin after topical administration of a high-concentration capsaicin patch to patients with peripheral neuropathic pain","volume":"31","author":"Babbar","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.coph.2019.05.008_bib0510","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1124\/jpet.103.054478","article-title":"Capsaicin-induced hyperalgesia and mu-opioid-induced antihyperalgesia in male and female Fischer 344 rats","volume":"307","author":"Barrett","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0515","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1124\/jpet.109.158402","article-title":"17Beta-estradiol mediates the sex difference in capsaicin-induced nociception in rats","volume":"331","author":"Lu","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0520","first-page":"148","article-title":"The effect of topical capsaicin-induced sensitization on heat-evoked cutaneous vasomotor responses","volume":"5","author":"Nielsen","year":"2013","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0525","first-page":"289","article-title":"Site-specific, dose-dependent, and sex-related responses to the experimental pain model induced by intradermal injection of capsaicin to the foreheads and forearms of healthy humans","volume":"21","author":"Gazerani","year":"2007","journal-title":"J Orofac Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0530","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.pain.2005.08.009","article-title":"A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences","volume":"118","author":"Gazerani","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0535","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.brainres.2009.04.005","article-title":"Sex differences in inflammation evoked by noxious chemical, heat and electrical stimulation","volume":"1276","author":"Carmichael","year":"2009","journal-title":"Brain Res"},{"key":"10.1016\/j.coph.2019.05.008_bib0540","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1472-8206.2004.00218.x","article-title":"Gender differences in regional cutaneous microcirculatory responses to capsaicin","volume":"18","author":"Ferrell","year":"2004","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0545","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.pain.2003.11.017","article-title":"Sex differences in pain perception and anxiety. A psychophysical study with topical capsaicin","volume":"108","author":"Frot","year":"2004","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0550","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2265.2007.02802.x","article-title":"The analgesic efficacy of lidocaine\/prilocaine (EMLA) cream during fine-needle aspiration biopsy of thyroid nodules","volume":"66","author":"Gursoy","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.coph.2019.05.008_bib0555","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.healun.2006.06.016","article-title":"Topical anesthesia with EMLA reduces pain during endomyocardial biopsy: a randomized trial","volume":"25","author":"Leloudis","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.coph.2019.05.008_bib0560","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0304-3959(98)00088-8","article-title":"Sex differences in response to cutaneous anesthesia: a double blind randomized study","volume":"77","author":"Robinson","year":"1998","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib0565","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/dsu.12064","article-title":"Serum lidocaine levels and cutaneous side effects after application of 23% lidocaine 7% tetracaine ointment to the face","volume":"39","author":"McCleskey","year":"2013","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.coph.2019.05.008_bib0570","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.117.4.1055","article-title":"Serum lidocaine concentrations in asthmatics undergoing research bronchoscopy","volume":"117","author":"Langmack","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.coph.2019.05.008_bib0575","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.0022-202X.2004.22725.x","article-title":"Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans","volume":"123","author":"Janjua","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0580","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/00926239708403923","article-title":"SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients","volume":"23","author":"Montejo-Gonzalez","year":"1997","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0585","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1176\/appi.ajp.157.9.1445","article-title":"Gender differences in treatment response to sertraline versus imipramine in chronic depression","volume":"157","author":"Kornstein","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0590","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1080\/00926230701385589","article-title":"Links among paroxetine-induced sexual dysfunctions, gender, and CYP2D6 activity","volume":"33","author":"Zourkov\u00e1","year":"2007","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0595","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1046\/j.1440-1614.2001.01026.x","article-title":"Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline","volume":"36","author":"Joyce","year":"2002","journal-title":"Aust New Zealand J Psychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0600","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/j.1552-4604.1998.tb04466.x","article-title":"Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers","volume":"38","author":"Scavone","year":"1998","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0605","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1093\/ajhp\/57.16.1499","article-title":"Pharmacokinetics of promethazine hydrochloride after administration of rectal suppositories and oral syrup to healthy subjects","volume":"57","author":"Strenkoski-Nix","year":"2000","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.coph.2019.05.008_bib0610","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0090-9556(25)00295-8","article-title":"Formation and urinary excretion of cyproheptadine glucuronide in monkeys, chimpanzees, and humans","volume":"8","author":"Fischer","year":"1980","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.coph.2019.05.008_bib0615","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1177\/0091270009340417","article-title":"Toward optimal treatment in women: the effect of sex on metoprolol-diphenhydramine interaction","volume":"50","author":"Sharma","year":"2010","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0620","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1001\/jama.1969.03160260020005","article-title":"Clinical effects of hypnotics. II. An epidemiologic study","volume":"209","author":"Shapiro","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2019.05.008_bib0625","doi-asserted-by":"crossref","DOI":"10.1186\/s40360-017-0177-y","article-title":"Use of a trigger tool to detect adverse drug reactions in an emergency department","volume":"18","author":"de Almeida","year":"2017","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/j.coph.2019.05.008_bib0630","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/pds.3455","article-title":"Use of QT-prolonging medications in US emergency departments, 1995-2009","volume":"23","author":"Tay","year":"2014","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.coph.2019.05.008_bib0635","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1046\/j.1365-2125.2003.02017.x","article-title":"Retrospective population pharmacokinetic analysis of cetirizine in children aged 6 months to 12 years","volume":"57","author":"Pitsiu","year":"2004","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0640","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2165\/00003088-200847040-00001","article-title":"Clinical pharmacokinetics and pharmacodynamics of desloratadine, fexofenadine and levocetirizine : a comparative review","volume":"47","author":"Devillier","year":"2008","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0645","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5414\/CPP39126","article-title":"Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects","volume":"39","author":"Rohatagi","year":"2001","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0650","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1177\/0091270006288733","article-title":"Time-dependent interaction between lopinavir\/ritonavir and fexofenadine","volume":"46","author":"van Heeswijk","year":"2006","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0655","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1046\/j.1365-2125.2002.01591.x","article-title":"MDR1 gene polymorphisms and disposition of the P-glycoprotein substrate fexofenadine","volume":"53","author":"Drescher","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0660","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1067\/mcp.2001.113697","article-title":"The effect of rifampin administration on the disposition of fexofenadine","volume":"69","author":"Hamman","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0665","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176091","article-title":"Population pharmacokinetic modelling of rupatadine solution in 6-11 year olds and optimisation of the experimental design in younger children","volume":"12","author":"Santamaria","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.008_bib0670","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.jpba.2008.03.015","article-title":"High performance liquid chromatography-tandem mass spectrometric determination of rupatadine in human plasma and its pharmacokinetics","volume":"47","author":"Tian","year":"2008","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.coph.2019.05.008_bib0675","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2500\/ajra.2014.28.4049","article-title":"Bilastine as a potential treatment in allergic rhinitis","volume":"28","author":"Kowal","year":"2014","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.coph.2019.05.008_bib0680","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2165\/11317180-000000000-00000","article-title":"Pharmacokinetic-pharmacodynamic modelling of the antihistaminic (H1) effect of bilastine","volume":"48","author":"Jauregizar","year":"2009","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0685","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1111\/j.1398-9995.2009.02217.x","article-title":"Comparison of the efficacy and safety of bilastine 20 mg vs levocetirizine 5 mg for the treatment of chronic idiopathic urticaria: a multi-centre, double-blind, randomized, placebo-controlled study","volume":"65","author":"Zuberbier","year":"2010","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2019.05.008_bib0690","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hup.2378","article-title":"Psychomotor and subjective effects of bilastine, hydroxyzine, and cetirizine, in combination with alcohol: a randomized, double-blind, crossover, and positive-controlled and placebo-controlled Phase I clinical trials","volume":"29","author":"Garcia-Gea","year":"2014","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0695","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/S1081-1206(10)61566-9","article-title":"Antihistamines and driving ability: evidence from on-the-road driving studies during normal traffic","volume":"92","author":"Verster","year":"2004","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coph.2019.05.008_bib0700","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1517\/14656566.5.1.125","article-title":"Review of cetirizine hydrochloride for the treatment of allergic disorders","volume":"5","author":"Portnoy","year":"2004","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.coph.2019.05.008_bib0705","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0090-9556(25)08072-9","article-title":"Metabolism of ketotifen by human liver microsomes. In vitro characterization of a tertiary amine glucuronidation","volume":"11","author":"Le Bigot","year":"1983","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.coph.2019.05.008_bib0710","first-page":"22","article-title":"Comparison of gabapentin and ketotifen in treatment of uremic pruritus in hemodialysis patients","volume":"32","author":"Amirkhanlou","year":"2016","journal-title":"Pak J Med Sci"},{"key":"10.1016\/j.coph.2019.05.008_bib0715","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1023\/A:1016056912698","article-title":"Pharmacokinetics, bioavailability, and safety of montelukast sodium (MK-0476) in healthy males and females","volume":"13","author":"Cheng","year":"1996","journal-title":"Pharm Res"},{"key":"10.1016\/j.coph.2019.05.008_bib0720","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1177\/00912700122012733","article-title":"Prednisolone pharmacokinetics and pharmacodynamics in relation to sex and race","volume":"41","author":"Magee","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0725","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2125.1984.tb02363.x","article-title":"Alterations in prednisolone disposition as a result of time of administration, gender and dose","volume":"17","author":"Meffin","year":"1984","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0730","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/clpt.1993.167","article-title":"Gender-based effects on methylprednisolone pharmacokinetics and pharmacodynamics","volume":"54","author":"Lew","year":"1993","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0735","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4530(02)00015-X","article-title":"Steroid-induced elevation of glucose in Alzheimer\u2019s disease: relationship to gender, apolipoprotein E genotype and cognition","volume":"28","author":"Aisen","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2019.05.008_bib0740","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MPG.0b013e31805b82c6","article-title":"Effect of long-term low-dose prednisone on height velocity and disease activity in pediatric and adolescent patients with Crohn disease","volume":"45","author":"Navarro","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.coph.2019.05.008_bib0745","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S0196-0644(95)70002-1","article-title":"Outpatient management of acute urticaria: the role of prednisone","volume":"26","author":"Pollack","year":"1995","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.coph.2019.05.008_bib0750","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ejps.2014.07.006","article-title":"Sex- and smoke-related differences in gastrointestinal transit of cyclosporin A microemulsion capsules","volume":"63","author":"Fagiolino","year":"2014","journal-title":"Eur J Pharm Sci"},{"key":"10.1016\/j.coph.2019.05.008_bib0755","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1007\/s12325-017-0526-7","article-title":"The GENDER ATTENTION observational study: gender and hormonal status differences in the incidence of adverse events during cyclosporine treatment in psoriatic patients","volume":"34","author":"Colombo","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib0760","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.3748\/wjg.v18.i47.6967","article-title":"Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease","volume":"18","author":"Zelinkova","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.coph.2019.05.008_bib0765","doi-asserted-by":"crossref","first-page":"143","DOI":"10.5021\/ad.2018.30.2.143","article-title":"Risk factors affecting adverse effects of cyclosporine A in a real-world psoriasis treatment","volume":"30","author":"Kim","year":"2018","journal-title":"Ann Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib0770","first-page":"179","article-title":"Double-masked trial of azathioprine in multiple sclerosis. British and Dutch Multiple Sclerosis Azathioprine Trial Group","volume":"2","author":"Office, BaDMSAT","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.coph.2019.05.008_bib0775","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0022-510X(82)90201-5","article-title":"Azathioprine in treatment of multiple sclerosis. Final results of a 41\/2-year controlled study of its effectiveness covering 115 patients","volume":"54","author":"Patzold","year":"1982","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.coph.2019.05.008_bib0780","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/ibd.21382","article-title":"Azathioprine is effective in corticosteroid-dependent Asian inflammatory bowel disease patients","volume":"17","author":"Thia","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2019.05.008_bib0785","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ibd.20041","article-title":"How adherent to treatment with azathioprine are patients with Crohn\u2019s disease in long-term remission?","volume":"13","author":"Mantzaris","year":"2007","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.coph.2019.05.008_bib0790","first-page":"769","article-title":"Adverse effects of azathioprine in the treatment of inflammatory bowel disease","volume":"93","author":"Martinez","year":"2001","journal-title":"Rev Esp Enferm Dig"},{"key":"10.1016\/j.coph.2019.05.008_bib0795","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s40262-014-0213-7","article-title":"Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients","volume":"54","author":"Tornatore","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0800","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2165\/00003088-200544100-00006","article-title":"Population pharmacokinetics of mycophenolic acid in renal transplant recipients","volume":"44","author":"van Hest","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0805","first-page":"658","article-title":"Pharmacokinetics of mycophenolic acid during the early period after renal transplant","volume":"5","author":"Nazemian","year":"2007","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.coph.2019.05.008_bib0810","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1046\/j.1600-6135.2003.00243.x","article-title":"Equivalent pharmacokinetics of mycophenolate mofetil in African-American and Caucasian male and female stable renal allograft recipients","volume":"3","author":"Pescovitz","year":"2003","journal-title":"Am J TransPlant"},{"key":"10.1016\/j.coph.2019.05.008_bib0815","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.seizure.2015.02.017","article-title":"Experience from therapeutic drug monitoring and gender aspects of gabapentin and pregabalin in clinical practice","volume":"28","author":"Johannessen Landmark","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.coph.2019.05.008_bib0820","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1528-1157.1999.tb00743.x","article-title":"Effects of age and gender on single-dose pharmacokinetics of gabapentin","volume":"40","author":"Boyd","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2019.05.008_bib0825","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1208\/s12248-016-0022-z","article-title":"Pharmacokinetics and saturable absorption of gabapentin in nursing home elderly patients","volume":"19","author":"Ahmed","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.coph.2019.05.008_bib0830","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1528-1167.2010.02933.x","article-title":"Population pharmacokinetics of pregabalin in healthy subjects and patients with chronic pain or partial seizures","volume":"52","author":"Bockbrader","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.coph.2019.05.008_bib0835","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2125.2011.03932.x","article-title":"Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy","volume":"72","author":"Shoji","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0840","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","article-title":"Gabapentin and uremic pruritus in hemodialysis patients","volume":"31","author":"Razeghi","year":"2009","journal-title":"Ren Fail"},{"key":"10.1016\/j.coph.2019.05.008_bib0845","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jsps.2014.10.004","article-title":"Safety of pregabalin among hemodialysis patients suffering from uremic pruritus","volume":"23","author":"Khan","year":"2015","journal-title":"Saudi Pharm J: SPJ"},{"key":"10.1016\/j.coph.2019.05.008_bib0850","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s00702-012-0952-2","article-title":"Effects of gender and age on serum concentrations of antidepressants under naturalistic conditions","volume":"120","author":"Unterecker","year":"2013","journal-title":"J Neural Transm"},{"key":"10.1016\/j.coph.2019.05.008_bib0855","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/FTD.0b013e31819114ea","article-title":"Serum concentrations of antidepressant drugs in a naturalistic setting: compilation based on a large therapeutic drug monitoring database","volume":"31","author":"Reis","year":"2009","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.coph.2019.05.008_bib0860","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2165\/00003088-200038060-00001","article-title":"Clinical pharmacokinetics of mirtazapine","volume":"38","author":"Timmer","year":"2000","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib0865","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/pds.1697","article-title":"Evaluation of risk factors for elevated tricyclic antidepressant plasma concentrations","volume":"18","author":"Billups","year":"2009","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.coph.2019.05.008_bib0870","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-2007-979552","article-title":"Low serum levels of tricyclic antidepressants in amitriptyline- and doxepin-treated inpatients with depressive syndromes are associated with nonresponse","volume":"29","author":"Rao","year":"1996","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0875","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00004714-199508000-00003","article-title":"Amitriptyline metabolism in elderly depressed patients and normal controls in relation to hypothalamic-pituitary-adrenal system function","volume":"15","author":"Schmider","year":"1995","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0880","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0165-0327(85)90012-6","article-title":"Cerebrospinal fluid levels of amitriptyline, nortriptyline, imipramine and desmethylimipramine. Relationship to plasma levels and treatment outcome","volume":"9","author":"Hanin","year":"1985","journal-title":"J Affect Disord"},{"key":"10.1016\/j.coph.2019.05.008_bib0885","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1019620","article-title":"On the relationship of nortriptyline: amitriptyline ratio to clinical improvement of amitriptyline treated depressive patients","volume":"13","author":"Jungkunz","year":"1980","journal-title":"Pharmakopsychiatr Neuropsychopharmakol"},{"key":"10.1016\/j.coph.2019.05.008_bib0890","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF02089958","article-title":"Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline","volume":"14","author":"Vandel","year":"1978","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0895","first-page":"37","article-title":"Weight gain during antidepressant therapy","volume":"26","author":"Sep-Kowalikowa","year":"1992","journal-title":"Psychiatr Pol"},{"key":"10.1016\/j.coph.2019.05.008_bib0900","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/ajmg.b.30462","article-title":"The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression","volume":"144B","author":"Tadic","year":"2007","journal-title":"Am J Med Genet B Neuropsychiatr Genet"},{"key":"10.1016\/j.coph.2019.05.008_bib0905","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13651500600579175","article-title":"The results of the Swiss observational study of the new, fast-dissolving mirtazapine formulation in depressed patients","volume":"10","author":"Delini-Stula","year":"2006","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.1016\/j.coph.2019.05.008_bib0910","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/gps.1779","article-title":"Are there predictors of outcome in depressed elderly nursing home residents during treatment with mirtazapine orally disintegrating tablets?","volume":"22","author":"Nelson","year":"2007","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0915","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/FTD.0b013e31817d6f5d","article-title":"CYP2D6 and ABCB1 genetic variability: influence on paroxetine plasma level and therapeutic response","volume":"30","author":"Gex-Fabry","year":"2008","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.coph.2019.05.008_bib0920","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hup.599","article-title":"Serum disposition of sertraline, N-desmethylsertraline and paroxetine: a pharmacokinetic evaluation of repeated drug concentration measurements during 6 months of treatment for major depression","volume":"19","author":"Reis","year":"2004","journal-title":"Hum Psychopharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2019.05.008_bib0925","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003088-199700321-00003","article-title":"Clinically relevant pharmacology of selective serotonin reuptake inhibitors. An overview with emphasis on pharmacokinetics and effects on oxidative drug metabolism","volume":"32","author":"Preskorn","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2019.05.008_bib0930","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2165\/00003088-199700321-00004","article-title":"Pharmacokinetics of sertraline and its N-demethyl metabolite in elderly and young male and female volunteers","volume":"32","author":"Ronfeld","year":"1997","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 2","key":"10.1016\/j.coph.2019.05.008_bib0935","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/00004850-199112002-00004","article-title":"Clinical implications of the pharmacology of sertraline","volume":"6","author":"Warrington","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0940","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/JCP.0000000000000121","article-title":"Plasma fluoxetine concentrations and clinical improvement in an adolescent sample diagnosed with major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder","volume":"34","author":"Bl\u00e1zquez","year":"2014","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0945","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000089825","article-title":"Pharmacokinetics of fluoxetine in elderly men and women","volume":"52","author":"Ferguson","year":"2006","journal-title":"Gerontology"},{"key":"10.1016\/j.coph.2019.05.008_bib0950","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/00007691-199808000-00016","article-title":"Nonlinear pharmacokinetics of fluvoxamine and gender differences","volume":"20","author":"H\u00e4rtter","year":"1998","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.coph.2019.05.008_bib0955","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/sj.npp.1300960","article-title":"Multiple dose pharmacokinetics of paroxetine in children and adolescents with major depressive disorder or obsessive-compulsive disorder","volume":"31","author":"Findling","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.coph.2019.05.008_bib0960","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s00228-004-0792-6","article-title":"Effects of dosage and CYP2D6-mutated allele on plasma concentration of paroxetine","volume":"60","author":"Sawamura","year":"2004","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0965","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1089\/cap.2006.16.117","article-title":"Drug concentration monitoring with tolerability and efficacy assessments during open-label, long-term sertraline treatment of children and adolescents","volume":"16","author":"Alderman","year":"2006","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0970","first-page":"191","article-title":"Comparative bioavailability\/ bioequivalence of two different sertraline formulations: a randomised, 2-period x 2-sequence, crossover clinical trial in healthy volunteers","volume":"55","author":"Almeida","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.coph.2019.05.008_bib0975","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1055\/s-0031-1291294","article-title":"Therapeutic drug monitoring of children and adolescents treated with fluoxetine","volume":"45","author":"Koelch","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib0980","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/hup.2240","article-title":"Plasma fluvoxamine levels and OCD symptoms\/response in adult patients","volume":"27","author":"Marazziti","year":"2012","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0985","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/hup.648","article-title":"Gender differences in clinical presentation and response to sertraline treatment of generalized anxiety disorder","volume":"20","author":"Steiner","year":"2005","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0990","first-page":"1","article-title":"Nortriptyline versus fluoxetine in the treatment of major depressive disorder: a six-month, double-blind clinical trial","volume":"4","author":"Hashemi","year":"2012","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib0995","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1176\/appi.ajp.159.11.1848","article-title":"Are there differences between women\u2019s and men\u2019s antidepressant responses?","volume":"159","author":"Quitkin","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib1000","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1440-1819.2007.01679.x","article-title":"Gender differences in the clinical effects of fluvoxamine and milnacipran in Japanese major depressive patients","volume":"61","author":"Naito","year":"2007","journal-title":"Psychiatry Clin Neurosci"},{"key":"10.1016\/j.coph.2019.05.008_bib1005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1034\/j.1600-0447.2003.00120.x","article-title":"A differential response to nortriptyline and fluoxetine in melancholic depression: the importance of age and gender","volume":"108","author":"Joyce","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.coph.2019.05.008_bib1010","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-2999(02)02274-4","article-title":"Sex-related differences in mechanical nociception and antinociception produced by mu- and kappa-opioid receptor agonists in rats","volume":"452","author":"Barrett","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1015","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2460\/ajvr.75.1.11","article-title":"Evaluation of thermal antinociceptive effects and pharmacokinetics after intramuscular administration of butorphanol tartrate to American kestrels (Falco sparverius)","volume":"75","author":"Guzman","year":"2014","journal-title":"Am J Vet Res"},{"key":"10.1016\/j.coph.2019.05.008_bib1020","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4103\/2229-516X.106350","article-title":"Comparative evaluation of recovery characteristics of fentanyl and butorphanol when used as supplement to propofol anaesthesia","volume":"2","author":"Arora","year":"2012","journal-title":"Int J Appl Basic Med Res"},{"key":"10.1016\/j.coph.2019.05.008_bib1025","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1526-4637.2011.01157.x","article-title":"Individual differences in morphine and butorphanol analgesia: a laboratory pain study","volume":"12","author":"Sibille","year":"2011","journal-title":"Pain Med"},{"key":"10.1016\/j.coph.2019.05.008_bib1030","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s002130000453","article-title":"Sex-related differences in the antinociceptive effects of opioids: importance of rat genotype, nociceptive stimulus intensity, and efficacy at the mu opioid receptor","volume":"150","author":"Cook","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2019.05.008_bib1035","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nm1196-1248","article-title":"Kappa-opioids produce significantly greater analgesia in women than in men","volume":"2","author":"Gear","year":"1996","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2019.05.008_bib1040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.pain.2010.09.018","article-title":"Sex-specificity and estrogen-dependence of kappa opioid receptor-mediated antinociception and antihyperalgesia","volume":"151","author":"Lawson","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib1045","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.joen.2008.01.021","article-title":"Gender differences in analgesia for endodontic pain","volume":"34","author":"Ryan","year":"2008","journal-title":"J Endod"},{"key":"10.1016\/j.coph.2019.05.008_bib1050","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/S0149-7634(00)00017-8","article-title":"Sex-related hormonal influences on pain and analgesic responses","volume":"24","author":"Fillingim","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.coph.2019.05.008_bib1055","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpain.2004.01.007","article-title":"Sex differences in opioid analgesia: clinical and experimental findings","volume":"8","author":"Fillingim","year":"2004","journal-title":"Eur J Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib1060","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jpain.2008.12.001","article-title":"Sex, gender, and pain: a review of recent clinical and experimental findings","volume":"10","author":"Fillingim","year":"2009","journal-title":"J Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib1065","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.pain.2010.06.012","article-title":"Do sex differences exist in opioid analgesia? A systematic review and meta-analysis of human experimental and clinical studies","volume":"151","author":"Niesters","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib1070","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0304-3940(96)12402-2","article-title":"Gender difference in analgesic response to the kappa-opioid pentazocine","volume":"205","author":"Gear","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.coph.2019.05.008_bib1075","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0009-9236(03)00152-8","article-title":"Side effects of opioids during short-term administration: effect of age, gender, and race","volume":"74","author":"Cepeda","year":"2003","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1080","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.pbb.2004.01.021","article-title":"The effects of a cold-water stimulus on butorphanol effects in males and females","volume":"78","author":"Zacny","year":"2004","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.coph.2019.05.008_bib1085","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000341268","article-title":"Efficacy and safety of a novel k-agonist for managing intractable pruritus in dialysis patients","volume":"36","author":"Kumagai","year":"2012","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.coph.2019.05.008_bib1090","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1517\/14656566.2012.693164","article-title":"Nalfurafine hydrochloride for the treatment of pruritus","volume":"13","author":"Inui","year":"2012","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.coph.2019.05.008_bib1095","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1530-0277.2006.00052.x","article-title":"Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone","volume":"30","author":"Dunbar","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.coph.2019.05.008_bib1100","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.jsat.2007.05.011","article-title":"Gender differences with high-dose naltrexone in patients with co-occurring cocaine and alcohol dependence","volume":"34","author":"Pettinati","year":"2008","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.coph.2019.05.008_bib1105","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/jama.293.13.1617","article-title":"Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial","volume":"293","author":"Garbutt","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.coph.2019.05.008_bib1110","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1111\/j.1530-0277.2006.00101.x","article-title":"Targeted versus daily naltrexone: secondary analysis of effects on average daily drinking","volume":"30","author":"Hernandez-Avila","year":"2006","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.coph.2019.05.008_bib1115","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1097\/JCP.0b013e3182676956","article-title":"Effects of naltrexone on smoking cessation outcomes and weight gain in nicotine-dependent men and women","volume":"32","author":"King","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/10550887.2016.1189659","article-title":"Gender differences in treatment and clinical characteristics among patients receiving extended release naltrexone","volume":"35","author":"Herbeck","year":"2016","journal-title":"J Addict Dis"},{"key":"10.1016\/j.coph.2019.05.008_bib1125","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/10550490802409074","article-title":"Gender differences in predictors of treatment attrition with high dose naltrexone in cocaine and alcohol dependence","volume":"17","author":"Suh","year":"2008","journal-title":"Am J Addict"},{"key":"10.1016\/j.coph.2019.05.008_bib1130","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s002130000666","article-title":"Adverse effects of oral naltrexone: analysis of data from two clinical trials","volume":"154","author":"Oncken","year":"2001","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2019.05.008_bib1135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/WNF.0000000000000152","article-title":"High-dose naltrexone treatment and gender in alcohol dependence","volume":"39","author":"Yoon","year":"2016","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1140","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.psyneuen.2014.10.013","article-title":"Sex differences in acute hormonal and subjective response to naltrexone: the impact of menstrual cycle phase","volume":"52","author":"Roche","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2019.05.008_bib1145","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.psyneuen.2006.02.003","article-title":"Gender differences in hypothalamic-pituitary-adrenal (HPA) axis reactivity","volume":"31","author":"Uhart","year":"2006","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.coph.2019.05.008_bib1150","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1248\/bpb.b12-01086","article-title":"Interindividual variations in aprepitant plasma pharmacokinetics in cancer patients receiving cisplatin-based chemotherapy for the first time","volume":"36","author":"Motohashi","year":"2013","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.coph.2019.05.008_bib1155","first-page":"1171","article-title":"Evaluation of risk factors predictive of nausea and vomiting with current standard-of-care antiemetic treatment: analysis of two phase III trials of aprepitant in patients receiving cisplatin-based chemotherapy","volume":"18","author":"Hesketh","year":"2010","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.coph.2019.05.008_bib1160","first-page":"354","article-title":"Combined data from two phase III trials of the NK1 antagonist aprepitant plus a 5HT 3 antagonist and a corticosteroid for prevention of chemotherapy-induced nausea and vomiting: effect of gender on treatment response","volume":"14","author":"Hesketh","year":"2006","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.coph.2019.05.008_bib1165","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1185\/03007995.2014.925866","article-title":"Efficacy of a triple antiemetic regimen with aprepitant for the prevention of chemotherapy-induced nausea and vomiting: effects of gender, age, and region","volume":"30","author":"Rapoport","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.coph.2019.05.008_bib1170","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000044967","article-title":"Histamine and serotonin in uremic pruritus: effect of ondansetron in CAPD-pruritic patients","volume":"78","author":"Balaskas","year":"1998","journal-title":"Nephron"},{"key":"10.1016\/j.coph.2019.05.008_bib1175","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/j.1875-9114.1998.tb03855.x","article-title":"Relative bioavailability of ondansetron 8-mg oral tablets versus two extemporaneous 16-mg suppositories: formulation and gender differences","volume":"18","author":"Jann","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"Suppl. 10","key":"10.1016\/j.coph.2019.05.008_bib1180","first-page":"9","article-title":"Ondansetron metabolism and pharmacokinetics","volume":"19","author":"Pritchard","year":"1992","journal-title":"Semin Oncol"},{"key":"10.1016\/j.coph.2019.05.008_bib1185","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1002\/bdd.627","article-title":"Gender differences in ondansetron pharmacokinetics in rats","volume":"29","author":"Yang","year":"2008","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.coph.2019.05.008_bib1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2011.05.001","article-title":"Treatment with propranolol of 6 patients with idiopathic aquagenic pruritus","volume":"128","author":"Nosbaum","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2019.05.008_bib1195","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/clpt.1985.216","article-title":"Biologic determinants of propranolol disposition: results from 1308 patients in the beta-blocker heart attack trial","volume":"38","author":"Walle","year":"1985","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1038\/clpt.1989.136","article-title":"Pathway-selective sex differences in the metabolic clearance of propranolol in human subjects","volume":"46","author":"Walle","year":"1989","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1205","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2165\/00003088-200342020-00001","article-title":"The influence of sex on pharmacokinetics","volume":"42","author":"Schwartz","year":"2003","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.coph.2019.05.008_bib1210","first-page":"468","article-title":"Sex differences in pharmacokinetics of oral propranolol in healthy Chinese volunteers","volume":"16","author":"Xie","year":"1995","journal-title":"Zhongguo Yao Li Xue Bao"},{"key":"10.1016\/j.coph.2019.05.008_bib1215","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3348\/kjr.2011.12.3.319","article-title":"Effects of propranolol on the left ventricular volume of normal subjects during CT coronary angiography","volume":"12","author":"Mo","year":"2011","journal-title":"Korean J Radiol"},{"key":"10.1016\/j.coph.2019.05.008_bib1220","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1053\/j.gastro.2012.12.005","article-title":"Sex and age are determinants of the clinical phenotype of primary biliary cirrhosis and response to ursodeoxycholic acid","volume":"144","author":"Carbone","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coph.2019.05.008_bib1225","first-page":"1","article-title":"Sex and gender differences in pharmacology","volume":"vol 214","author":"Regitz-Zagrosek","year":"2012"},{"key":"10.1016\/j.coph.2019.05.008_bib1230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/bph.12362","article-title":"Pharmacogenomics, pharmacokinetics and pharmacodynamics: interaction with biological differences between men and women","volume":"171","author":"Franconi","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1235","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/bmj.329.7456.15","article-title":"Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients","volume":"329","author":"Pirmohamed","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.coph.2019.05.008_bib1240","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004439","article-title":"Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes","volume":"4","author":"Davies","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.coph.2019.05.008_bib1245","first-page":"1854","article-title":"Significance of age, sex, kidney function, atopy and number of prescriptions for the occurrence of adverse drug reactions, studied by multivariate statistical methods. Results from the Comprehensive Hospital Drug Monitoring Berne (CHDMB)","volume":"114","author":"Hoigne","year":"1984","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/j.coph.2019.05.008_bib1250","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2165\/00002018-200831090-00007","article-title":"Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals","volume":"31","author":"Zopf","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.coph.2019.05.008_bib1255","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001315","article-title":"Association of extrarenal adverse effects of posttransplant immunosuppression with sex and ABCB1 haplotypes","volume":"94","author":"Venuto","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.coph.2019.05.008_bib1260","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1016\/j.transproceed.2014.09.155","article-title":"Gastrointestinal disorders after renal transplantation","volume":"46","author":"Savvidaki","year":"2014","journal-title":"Transplant Proc"},{"key":"10.1016\/j.coph.2019.05.008_bib1265","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s12325-013-0056-x","article-title":"Drug-induced long QT syndrome in women","volume":"30","author":"Li","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1270","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","article-title":"Risk factors for QTc-prolongation: systematic review of the evidence","volume":"39","author":"Vandael","year":"2017","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.coph.2019.05.008_bib1275","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1055\/s-0032-1308969","article-title":"Pharmacotherapeutic determinants for QTc interval prolongation in Japanese patients with mood disorder","volume":"45","author":"Okayasu","year":"2012","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.coph.2019.05.008_bib1280","first-page":"250","article-title":"Causes and management of drug-induced long QT syndrome","volume":"23","author":"Ayad","year":"2010","journal-title":"Proceedings (Bayl Univ Med Cent)"},{"key":"10.1016\/j.coph.2019.05.008_bib1285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1751-7117.2009.00021.x","article-title":"Acquired QT prolongation","volume":"24","author":"Cahoon","year":"2009","journal-title":"Prog Cardiovasc Nurs"},{"key":"10.1016\/j.coph.2019.05.008_bib1290","first-page":"53","article-title":"Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study","volume":"3","author":"Hafermann","year":"2011","journal-title":"Drug Healthc Patient Saf"},{"key":"10.1016\/j.coph.2019.05.008_bib1295","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1067\/mcp.2000.105761","article-title":"Greater quinidine-induced QTc interval prolongation in women","volume":"67","author":"Benton","year":"2000","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1300","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1002\/jcph.123","article-title":"Sex differences in cyclosporine pharmacokinetics and ABCB1 gene expression in mononuclear blood cells in African American and Caucasian renal transplant recipients","volume":"53","author":"Tornatore","year":"2013","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1305","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1600-0447.1983.tb09717.x","article-title":"Relationship between tricyclic antidepressant plasma levels and clinical response in patients treated with desipramine or doxepin","volume":"67","author":"Brunswick","year":"1983","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.coph.2019.05.008_bib1310","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1007\/BF03018737","article-title":"Postoperative pain and analgesic responses are similar in male and female Sprague-Dawley rats","volume":"50","author":"Kroin","year":"2003","journal-title":"Can J Anaesth"},{"key":"10.1016\/j.coph.2019.05.008_bib1315","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00415-017-8526-8","article-title":"Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market","volume":"264","author":"Makinen","year":"2017","journal-title":"J Neurol"},{"key":"10.1016\/j.coph.2019.05.008_bib1320","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2125.2011.03932.x","article-title":"Population pharmacokinetics of pregabalin in healthy subjects and patients with post-herpetic neuralgia or diabetic peripheral neuropathy","volume":"72","author":"Shoji","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1325","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jocn.2017.10.039","article-title":"Pregabalin as a salvage preoperative treatment for refractory trigeminal neuralgia","volume":"47","author":"Hamasaki","year":"2018","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.coph.2019.05.008_bib1330","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/ejp.763","article-title":"Are there different predictors of analgesic response between antidepressants and anticonvulsants in painful diabetic neuropathy?","volume":"20","author":"Marchettini","year":"2016","journal-title":"Eur J Pain"},{"key":"10.1016\/j.coph.2019.05.008_bib1335","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaad.2017.08.025","article-title":"Use of oral antidepressants in patients with chronic pruritus: a systematic review","volume":"77","author":"Kouwenhoven","year":"2017","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib1340","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00213-003-1577-9","article-title":"Gender difference in the prevention of hyperanxiety in adult prenatally stressed rats by chronic treatment with amitriptyline","volume":"171","author":"Poltyrev","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.coph.2019.05.008_bib1345","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/026988110201600104","article-title":"Effects of emedastine and cetirizine, alone and with alcohol, on actual driving of males and females","volume":"16","author":"Vermeeren","year":"2002","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1472-8206.2001.00035.x","article-title":"Absorption and disposition of levocetirizine, the eutomer of cetirizine, administered alone or as cetirizine to healthy volunteers","volume":"15","author":"Baltes","year":"2001","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1355","doi-asserted-by":"crossref","first-page":"352","DOI":"10.5152\/balkanmedj.2015.15884","article-title":"In vivo anti-inflammatory effect of H1 antihistamines in allergic rhinitis: a randomized clinical trial","volume":"32","author":"Bocsan","year":"2015","journal-title":"Balkan Med J"},{"key":"10.1016\/j.coph.2019.05.008_bib1360","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1185\/03007995.2010.537319","article-title":"Improving SAR symptoms with levocetirizine: evaluating active and placebo effects in pollen challenge vs. natural exposure studies","volume":"27","author":"Boev","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.coph.2019.05.008_bib1365","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00498250500038906","article-title":"Metabolism and excretion of loratadine in male and female mice, rats and monkeys","volume":"35","author":"Ramanathan","year":"2005","journal-title":"Xenobiotica"},{"key":"10.1016\/j.coph.2019.05.008_bib1370","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2165\/00128071-200708050-00002","article-title":"Desloratadine for chronic idiopathic urticaria: a review of clinical efficacy","volume":"8","author":"DuBuske","year":"2007","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.coph.2019.05.008_bib1375","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1517\/13543784.10.3.547","article-title":"Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug","volume":"10","author":"Agrawal","year":"2001","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/j.coph.2019.05.008_bib1380","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1067\/mai.2001.114239","article-title":"Desloratadine: a new, nonsedating, oral antihistamine","volume":"107","author":"Geha","year":"2001","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2019.05.008_bib1385","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003088-200241001-00004","article-title":"Effect of race and sex on single and multiple dose pharmacokinetics of desloratadine","volume":"41","author":"Affrime","year":"2002","journal-title":"Clin Pharmacokinet"},{"issue":"Suppl. 65","key":"10.1016\/j.coph.2019.05.008_bib1390","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1034\/j.1398-9995.2001.00101.x","article-title":"The pharmacologic profile of desloratadine: a review","volume":"56","author":"Henz","year":"2001","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2019.05.008_bib1395","doi-asserted-by":"crossref","first-page":"880","DOI":"10.5414\/CP201968","article-title":"The role of multidrug resistance-1 (MDR1) variants in response to fexofenadine among Jordanians","volume":"51","author":"Alzoubi","year":"2013","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1400","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF00193479","article-title":"The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol","volume":"47","author":"Shyu","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.coph.2019.05.008_bib1405","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/bdd.554","article-title":"Pharmacokinetic aspects of naloxone-precipitated morphine withdrawal in male and female prepubertal mice","volume":"28","author":"Diaz","year":"2007","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/j.coph.2019.05.008_bib1410","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/0196-9781(93)90077-T","article-title":"Sex differences in naloxone- and Tyr-MIF-1-induced hypoalgesia","volume":"14","author":"Kavaliers","year":"1993","journal-title":"Peptides"},{"key":"10.1016\/j.coph.2019.05.008_bib1415","series-title":"Emend (aprepitant) [package insert]","year":"2017"},{"key":"10.1016\/j.coph.2019.05.008_bib1420","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/00008506-200204000-00003","article-title":"A randomized, double-blind comparison of ondansetron versus placebo for prevention of nausea and vomiting after infratentorial craniotomy","volume":"14","author":"Fabling","year":"2002","journal-title":"J Neurosurg Anesthesiol"},{"key":"10.1016\/j.coph.2019.05.008_bib1425","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/bjc.1992.241","volume":"66","author":"Seynaeve","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.coph.2019.05.008_bib1430","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/clpt.1994.115","article-title":"Propranolol metabolism in normal subjects: association with sex steroid hormones","volume":"56","author":"Walle","year":"1994","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.coph.2019.05.008_bib1435","doi-asserted-by":"crossref","first-page":"e702","DOI":"10.1542\/peds.2006-3317","article-title":"Attenuation of the September epidemic of asthma exacerbations in children: a randomized, controlled trial of montelukast added to usual therapy","volume":"120","author":"Johnston","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.coph.2019.05.008_bib1440","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.bbrc.2017.11.042","article-title":"Cyclosporine A exhibits gender-specific nephrotoxicity in rats: Effect on renal tissue inflammation","volume":"495","author":"El-Bassossy","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2019.05.008_bib1445","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1210\/en.2002-220513","article-title":"Skeletal effects of cyclosporin A are gender related in rats","volume":"144","author":"Erben","year":"2003","journal-title":"Endocrinology"},{"key":"10.1016\/j.coph.2019.05.008_bib1450","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bone.2011.10.005","article-title":"Gender- and dose-related effects of cyclosporin A on hepatic and bone metabolism","volume":"50","author":"Jager","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.coph.2019.05.008_bib1455","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1124\/dmd.106.012013","article-title":"Gender-related differences in mycophenolate mofetil-induced gastrointestinal toxicity in rats","volume":"35","author":"Stern","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.coph.2019.05.008_bib1460","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1196\/annals.1351.030","article-title":"Is the course of steroid-treated polymyalgia rheumatica more severe in women?","volume":"1069","author":"Cimmino","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.coph.2019.05.008_bib1465","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00296-003-0411-3","article-title":"The effect of low-dose prednisone on bone mineral density in Peruvian rheumatoid arthritis patients","volume":"25","author":"Chung","year":"2005","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.coph.2019.05.008_bib1470","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0169-6009(08)80158-4","article-title":"Bone density and turnover in Addison's disease: effect of glucocorticoid treatment","volume":"26","author":"Valero","year":"1994","journal-title":"Bone Mineral"},{"key":"10.1016\/j.coph.2019.05.008_bib1475","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","article-title":"Long-term follow-up of bone mineral density in Addison's disease","volume":"58","author":"Jodar","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.coph.2019.05.008_bib1480","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0953-6205(02)00129-2","article-title":"Peripheral bone density in patients with rheumatoid arthritis and factors which influence it","volume":"13","author":"Kelly","year":"2002","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.coph.2019.05.008_bib1485","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.leu.2402078","article-title":"Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development","volume":"15","author":"Kaste","year":"2001","journal-title":"Leukemia"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921930027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147148921930027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T06:49:42Z","timestamp":1761461382000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147148921930027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":297,"alternative-id":["S147148921930027X"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2019.05.008","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sex differences in the pharmacology of itch therapies\u2014a narrative review","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2019.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}